MedPath

Assessment of the effect of portal venous embolization by MRI uging liver specificity contrast material

Not Applicable
Recruiting
Conditions
Hepatobiliary malignancy
Registration Number
JPRN-UMIN000003079
Lead Sponsor
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria 1. A patient with hypersensitivity to EOB-Primovist or Gadrinium. 2. A patient with asthma. 3. A patient with sever renal dysfunction. 4. A patient with pregnancy. 5. A woman with breast-feeding. 6. A patient with severe claustrophobia or nyctophobia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time intensity curve of the contrast material of embolized and non-embolized liver. The level of intensity at the hepatobiliary phase of embolized and non-embolized liver.
Secondary Outcome Measures
NameTimeMethod
liver function test blood concentration of primobist pathological findings of resected specimen
© Copyright 2025. All Rights Reserved by MedPath